NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A2

Company

Trevi Therapeutics, Inc.

Filed

November 2, 2021

Accession Number

0001072613-21-000615